# Talosix > Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04. - **Business Profile:** https://optimly.ai/brand/talosix - **Dataset:** https://optimly.ai/brand/talosix.json - **Markdown:** https://optimly.ai/brand/talosix/llms.txt - **Official website:** https://talosix.com - **Slug:** talosix - **Categories:** ai-machine-learning, healthcare-it ## Overview - **Tagline:** AI-powered platform that simplifies patient recruitment from identification to enrollment with real-time insights and personalized engagement. It offers a comprehensive, secure, and compliant platform for collecting, storing, analyzing, and reporting clinical and non-clinical real-world data, leveraging AI for automation and prediction, backed by expert support. Source: Brand's website (https://talosix.com) · 2026-10-04 - **Description:** Talosix offers an AI-powered platform and professional services to streamline clinical trials for sponsors, CROs, and providers. It focuses on patient recruitment, clinical data collection, engagement, and advanced analytics from real-world settings to enhance research efficiency and outcomes. Source: Brand's website (https://talosix.com) · 2026-10-04 ## Offerings - **Core capabilities:** - AI-powered clinical trial management platform - real-world data collection and analysis technology - patient screening - decentralized platform - electronic data capture (EDC) - patient engagement tools - DICOM Viewer - data integration; Professional services include study planning - account management - tailored solutions - data analysis & reporting - training services - and compliance support. Source: Brand's website (https://talosix.com) · 2026-10-04 - **Pricing:** Not disclosed Source: Brand's website (https://talosix.com) · 2026-10-04 ## Audience - **Target industry:** Clinical Research Organizations (CROs), Pharmaceutical/Biotech Sponsors, Healthcare Providers (conducting clinical research). Source: Brand's website (https://talosix.com) · 2026-10-04 Page last updated 2026-10-17.